LUCD
Lucid Diagnostics Inc
NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES
$1.07
+3.88% today
Updated 2026-04-30
Market cap
$199.66M
P/E ratio
—
P/S ratio
42.43x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Lucid Diagnostics Inc (LUCD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-932.00%
ROE
-711.00%
ROA
-87.20%
Debt/equity
0.94x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-1.13M | — | — | — |
| 2019 | $0.00 | $-4.42M | — | — | — |
| 2020 | $0.00 | $-8.28M | — | — | — |
| 2021 | $500000.00 | $-28.08M | -17.00% | -5,483.80% | -5,615.60% |
| 2022 | $377000.00 | $-56.17M | -858.62% | -14,899.47% | -14,899.47% |
| 2023 | $2.43M | $-52.67M | -249.18% | -1,996.79% | -2,169.11% |
| 2024 | $4.35M | $-45.53M | -90.20% | -1,059.64% | -1,047.61% |
| 2025 | $4.71M | $-58.01M | -60.26% | -1,054.82% | -1,232.68% |